pyrrolidonecarboxylic acid has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fossati, G; Kapuvári, B; Mező, G; Ranđelović, I; Schuster, S; Steinkühler, C; Tóvári, J | 1 |
| Gacs, A; Hegedüs, R; Kapuvári, B; Manea, M; Mező, G; Schulcz, Á; Tóvári, J; Vincze, B | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Disease Models, Animal; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Molecular Structure; Pyrrolidonecarboxylic Acid; Receptors, Cell Surface; RNA, Messenger; Toxicity Tests; Xenograft Model Antitumor Assays | 2019 |
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Butyric Acid; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Heart; HT29 Cells; Humans; Liver; Male; Mice; Neovascularization, Pathologic; Pyrrolidonecarboxylic Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |